Related references
Note: Only part of the references are listed.Pharmacogenetics of asthma
John J. Lima et al.
CURRENT OPINION IN PULMONARY MEDICINE (2009)
Involvement of Influx and Efflux Transport Systems in Gastrointestinal Absorption of Celiprolol
Yukio Kato et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Concentration-Dependent Effect of Naringin on Intestinal Absorption of β1-Adrenoceptor Antagonist Talinolol Mediated by P-Glycoprotein and Organic Anion Transporting Polypeptide (Oatp)
Yoshiyuki Shirasaka et al.
PHARMACEUTICAL RESEARCH (2009)
Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response
Edward B. Mougey et al.
PHARMACOGENETICS AND GENOMICS (2009)
5-Lipoxygenase pharmacogenetics in asthma: overlap with Cys-leukotriene receptor antagonist loci
Kelan G. Tantisira et al.
PHARMACOGENETICS AND GENOMICS (2009)
ALOX5 promoter genotype and response to montelukast in moderate persistent asthma
Juan J. Telleria et al.
RESPIRATORY MEDICINE (2008)
Genetic influences on response to asthma pharmacotherapy
John J Lima
Expert Review of Clinical Pharmacology (2008)
Effects of clarithromycin and grapefruit juice on the pharmacokinetics of glibenclamide
Jari J. Lilja et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice
D. G. Bailey et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Intestinal drug transporter expression and the impact of grapefruit juice in humans
H. Glaeser et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Pharmacogenetics of the 5-lipoxygenase biosynthetic pathway and variable clinical response to montelukast
Michael Klotsman et al.
PHARMACOGENETICS AND GENOMICS (2007)
Treatment heterogeneity in asthma - Genetics of response to leukotriene modifiers
John J. Lima
MOLECULAR DIAGNOSIS & THERAPY (2007)
Influence of leukotriene pathway polymorphisms on response to montelukast in asthma
JJ Lima et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Variation of flavonoids and furanocoumarins in grapefruit juices: A potential source of variability in grapefruit juice-drug interaction studies
WV De Castro et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2006)
Grapefruit juice ingestion significantly reduces talinolol bioavailability
UI Schwarz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B
H Satoh et al.
DRUG METABOLISM AND DISPOSITION (2005)
Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: Possible role of organic anion transporting polypeptides
GK Dresser et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Characterization of within-subject responses to fluticasone and montelukast in childhood asthma
SJ Szefler et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Undesirable effects of citrus juice on the pharmacokinetics of drugs - Focus on recent studies
M Saito et al.
DRUG SAFETY (2005)
Effects of grapefruit juice on pharmacokinetics of atorvastatin and pravastatin in Japanese
I Fukazawa et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Orange juice substantially reduces the bioavailability of the β-adrenergic-blocking agent celiprolol
JJ Lilja et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Functional characterization of pH-sensitive organic anion transporting polypeptide OATP-B in human
T Nozawa et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux
Y Honda et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
The effects of fruit juices on drug disposition: a new model for drug interactions
GK Dresser et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2003)
Itraconazole increases but grapefruit juice greatly decreases plasma concentrations of celiprolol
JJ Lilja et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Effect of montelukast on time-course of exhaled nitric oxide in asthma: Influence of LTC4 synthase A(-444)C polymorphism
GJ Whelan et al.
PEDIATRIC PULMONOLOGY (2003)
Leukotriene C4 synthase gene A(-444)C polymorphism and clinical response to a CYS-LT1 antagonist, pranlukast, in Japanese patients with moderate asthma
K Asano et al.
PHARMACOGENETICS (2002)
Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine
GK Dresser et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Grapefruit juice reduces the oral bioavailability of fexofenadine but not desloratadine
C Banfield et al.
CLINICAL PHARMACOKINETICS (2002)
Inhibition of P-glycoprotein transport function by grapefruit juice psoralen
EJ Wang et al.
PHARMACEUTICAL RESEARCH (2001)
Variant LTC4 synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast
AP Sampson et al.
THORAX (2000)
Effect of furanocoumarin derivatives in grapefruit juice on the uptake of vinblastine by Caco-2 cells and on the activity of cytochrome P450 3A4
A Ohnishi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Montelukast - A review of its therapeutic potential in persistent asthma
B Jarvis et al.
DRUGS (2000)
Heterogeneity of therapeutic responses in asthma
JM Drazen et al.
BRITISH MEDICAL BULLETIN (2000)
Share Paper
